Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000757656 | SCV000885957 | pathogenic | not provided | 2018-04-18 | criteria provided, single submitter | clinical testing | The PKD1 c.7751_7754delTCAC; p.Leu2584fs variant, to our knowledge, has not been reported in the medical literature or in gene-specific databases. It is also absent from the general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. This variant creates a frameshift by deleting 4 nucleotides, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Additionally, another variant that creates a frameshift at this codon (c.7750delC) has been described in at least one individual affected with autosomal dominant polycystic kidney disease and is considered pathogenic (Audrezet 2012). Based on available information, this variant is considered pathogenic. References: Audrezet M et al. Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients. Hum Mutat. 2012 Aug;33(8):1239-50. |